Haakenstad A O, Case J B, Mannik M
J Immunol. 1975 Apr;114(4):1153-60.
The effect of cortisone treatment on the disappearance kinetics, the hepatic uptake, and the glomerular deposition of i.v. administered, soluble immune complexes (HSAantiHSA) was examined in mice. An initial rapid disappearance of complexes from the circulation occurred after the injection of complexes into control mice, which was caused by increased vascular permeability. This phase was absent in the cortisone-treated group. The half life of complexes composed of more than two antigen and two antibody molecules (greater than Ag2Ab2)was prolonged from 1.93 hr in control mice to 4.71 hr in cortisone-treated mice while the half life of Ag2Ab2 complexes was unchanged (11.40 hr vs 12.04 hr). Although the clearance velocity of greater than Ag2Ab2 complexes was suppressed in cortisone-treated mice, the quantity of complexes specifically located in the liver at 1, 2, and 4 hr was not significantly different in the two groups. Persistence of circulating greater than Ag1Ab2 complexes was associated with enhanced and prolonged glomerular depostion of complexes in the cortisone-treated mice.
在小鼠中检测了可的松治疗对静脉注射的可溶性免疫复合物(HSA-antiHSA)的消失动力学、肝脏摄取及肾小球沉积的影响。将复合物注射到对照小鼠体内后,循环中的复合物最初迅速消失,这是由血管通透性增加所致。可的松治疗组不存在这一阶段。由两个以上抗原和两个以上抗体分子组成的复合物(大于Ag2Ab2)的半衰期从对照小鼠的1.93小时延长至可的松治疗小鼠的4.71小时,而Ag2Ab2复合物的半衰期未改变(分别为11.40小时和12.04小时)。虽然在可的松治疗的小鼠中大于Ag2Ab2复合物的清除速度受到抑制,但两组在1、2和4小时时肝脏中特异性定位的复合物数量无显著差异。在可的松治疗的小鼠中,循环中大于Ag1Ab2复合物的持续存在与复合物在肾小球的沉积增强和持续时间延长有关。